Working… Menu

Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03591094
Recruitment Status : Completed
First Posted : July 18, 2018
Last Update Posted : February 27, 2020
Information provided by (Responsible Party):
Proteostasis Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 18, 2019
Actual Study Completion Date : February 18, 2019
Certification/Extension First Submitted : February 25, 2020